ENVX / Enovix Corporation - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

Exhibit 99.1 Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025 Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Frida

a991prconfirmingalternat Exhibit 99.1 Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025 Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Friday, August 29, 2025 Last Day of Warrant Trading on Nasdaq is Friday, August 29, 2025 Notice of Guaranteed Delivery is Availabl

Exhibit 99.2 Notice of Guaranteed Delivery for Exercise of Warrants of Enovix Corporation (Not to be used for Signature Guarantees) This Notice of Guaranteed Delivery is provided by Enovix Corporation (the “Company”) with respect to the Company’s out

a992noticeofguaranteedde Exhibit 99.2 Notice of Guaranteed Delivery for Exercise of Warrants of Enovix Corporation (Not to be used for Signature Guarantees) This Notice of Guaranteed Delivery is provided by Enovix Corporation (the “Company”) with respect to the Company’s outstanding Warrants (the “Warrants”) to purchase shares of the Company’s common stock, $0.0001 par value per share (the “Common

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Enovix Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Enovix Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

Early Expiration Price Condition for Warrants Satisfied Alternate Expiration Date Elected Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Friday, August 29, 2025 Last Day of Warrant Trading on Nasdaq is Friday, August 29, 2025 Not

a991warrantalternateexpi Early Expiration Price Condition for Warrants Satisfied Alternate Expiration Date Elected Warrants Must be Exercised Prior to 5:00 p.

Enovix Appoints Veteran Semiconductor Leader J. Daniel “Dan” McCranie to its Board of Directors

Exhibit 99.1 Enovix Appoints Veteran Semiconductor Leader J. Daniel “Dan” McCranie to its Board of Directors FREMONT, Calif., August 14, 2025 - Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced the appointment of J. Daniel “Dan” McCranie to its Board of Directors (the “Board”), effective August 12, 2025. This appointm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 Enovix Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2025 o TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specifie

1 Fellow Shareholders, July 31, 2025 The company made progress in Q2 on all fronts: We launched our AI-1TM product platform, hit key milestones with strategic customers, and launched a warrant dividend to simultaneously reward our shareholders and fu

ex99-q22025financialresu 1 Fellow Shareholders, July 31, 2025 The company made progress in Q2 on all fronts: We launched our AI-1TM product platform, hit key milestones with strategic customers, and launched a warrant dividend to simultaneously reward our shareholders and fund our growth.

Early Warrant Expiration: Preliminary Notice Price of Enovix common stock has exceeded $10.50 for five trading days The earliest expiration date for the Warrants is August 19, 2025 Reserves right to set Alternate Expiration Date for Warrants

Exhibit 99.1 Early Warrant Expiration: Preliminary Notice Price of Enovix common stock has exceeded $10.50 for five trading days The earliest expiration date for the Warrants is August 19, 2025 Reserves right to set Alternate Expiration Date for Warrants FREMONT, Calif., July 28, 2025 - Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technolog

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2025 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

29,233,276 Shares of Common Stock

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-273858 Prospectus Supplement (To Prospectus dated August 18, 2023) 29,233,276 Shares of Common Stock This prospectus supplement relates to the issuance and sale of up to 29,233,276 shares of Common Stock, par value $0.0001 per share (the “Common Stock”), by Enovix Corporation, a Delaware corporation (“Enovix,” “Company,” “we,”

Warrant Agreement (including Form of Warrant), dated July 21, 2025, between the Company, Computershare Inc., a Delaware corporation, and Computershare Trust Company, N.A., as Warrant Agent.

Exhibit 4.1 WARRANT AGREEMENT Dated as of JULY 21, 2025 between ENOVIX CORPORATION and COMPUTERSHARE TRUST COMPANY N.A. as Warrant Agent Warrants for Shares of Common Stock of ENOVIX CORPORATION Table of Contents TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01 Definitions 4 Section 1.02 Other Definitions 9 Section 1.03 Rules of Construction 9 ARTICLE II FORM OF WARRANT; BENEFICIAL INTERE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Enovix Corporation (Exact n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 35

Enovix Distributes Dividend of Warrants to Stockholders

Exhibit 99.1 Enovix Distributes Dividend of Warrants to Stockholders FREMONT, Calif., July 21, 2025 – Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company, today announced that it will distribute warrants to purchase Enovix common stock (“Warrants”) to its shareholders and certain convertible noteholders on Monday, July 21, 2025 (the “Distribution Da

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2025 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

Form of Warrant Agreement between Computershare Inc., and its affiliate, Computershare Trust Company, N.A. and the Registrant (including the form of Warrant)

Exhibit 4.1 WARRANT AGREEMENT Dated as of JULY 21, 2025 between ENOVIX CORPORATION and COMPUTERSHARE TRUST COMPANY N.A. as Warrant Agent Warrants for Shares of Common Stock of ENOVIX CORPORATION Table of Contents TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01 Definitions 4 Section 1.02 Other Definitions 9 Section 1.03 Rules of Construction 9 ARTICLE II FORM OF WARRANT; BENEFICIAL INTERE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Enovix Corporation (Exact name of registrant as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 3501 W Warren Avenue F

Form of Warrant Agreement between Computershare Inc., and its affiliate, Computershare Trust Company, N.A. and the Registrant (including the form of Warrant)

Exhibit 4.1 WARRANT AGREEMENT Dated as of JULY , 2025 between ENOVIX CORPORATION and COMPUTERSHARE TRUST COMPANY N.A. as Warrant Agent Warrants for Shares of Common Stock of ENOVIX CORPORATION TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01 Definitions 4 Section 1.02 Other Definitions 8 Section 1.03 Rules of Construction 9 ARTICLE II FORM OF WARRANT; BENEFICIAL INTERESTS Section 2.01 Iss

1 Enovix Stockholder FAQ Warrant Dividend Distribution What is a Warrant? A Warrant is an option to buy common shares issued directly by a company. Like any option, it gives the holder the right, but not the obligation, to purchase a share of common

1 Enovix Stockholder FAQ Warrant Dividend Distribution What is a Warrant? A Warrant is an option to buy common shares issued directly by a company.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

1 Enovix Stockholder FAQ Warrant Dividend Distribution Supplement # 1 What happens if I hold my Enovix shares in a margin account and the shares are on loan as of the July 17, 2025 record date? If your Enovix shares are in a margin account, your brok

envxwarrantsuppfaqsex99 1 Enovix Stockholder FAQ Warrant Dividend Distribution Supplement # 1 What happens if I hold my Enovix shares in a margin account and the shares are on loan as of the July 17, 2025 record date? If your Enovix shares are in a margin account, your broker may loan out your shares – often without notifying you.

Enovix Releases Supplemental FAQ to Support Warrant Dividend Distribution Answers questions related to margin accounts, eligibility mechanics, and trading logistics

Exhibit 99.1 Enovix Releases Supplemental FAQ to Support Warrant Dividend Distribution Answers questions related to margin accounts, eligibility mechanics, and trading logistics FREMONT, Calif., July 15, 2025 – Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company, today released a supplemental Frequently Asked Question (FAQ) document relating to the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Enovix Corporation (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Enovix Announces Preliminary Second Quarter 2025 Financial Results Q2 Revenue Exceeds High-End of Guidance, Up 98% Year Over Year

Exhibit 99.1 Enovix Announces Preliminary Second Quarter 2025 Financial Results Q2 Revenue Exceeds High-End of Guidance, Up 98% Year Over Year FREMONT, Calif., July 7, 2025 - Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company, today announced preliminary selected unaudited financial results for the second quarter ended June 29, 2025: •Revenue was $

1 Enovix Stockholder FAQ Warrant Dividend Distribution What is a Warrant? A Warrant is an option to buy common shares issued directly by a company. Like any option, it gives the holder the right, but not the obligation, to purchase a share of common

envxwarrantdividendfaqs 1 Enovix Stockholder FAQ Warrant Dividend Distribution What is a Warrant? A Warrant is an option to buy common shares issued directly by a company.

Enovix Declares Shareholder Warrant Dividend Warrant dividend follows major operational milestone: Launch of AI-1TM, a Revolutionary Silicon-Anode Smartphone Battery Platform

Exhibit 99.1 Enovix Declares Shareholder Warrant Dividend Warrant dividend follows major operational milestone: Launch of AI-1TM, a Revolutionary Silicon-Anode Smartphone Battery Platform FREMONT, Calif., July 7, 2025 – Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a global high-performance battery company, today announced a special dividend in the form of warrants to holders of the C

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Enovix Corporation Announces Share Repurchase Program

Exhibit 99.1 Enovix Corporation Announces Share Repurchase Program FREMONT, Calif., July 2, 2025 (GLOBE NEWSWIRE) - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced that its Board of Directors has authorized a share repurchase program under which the company may repurchase up to $60 million of its outstanding common stock. The repurchase prog

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2025 o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specifi

Form of 2025 Performance Stock Unit Award Grant Notice and Agreement under the 2021 Equity Incentive Plan

Exhibit 10.2 ENOVIX CORPORATION 2021 EQUITY INCENTIVE AWARD PLAN PERFORMANCE STOCK UNIT AWARD GRANT NOTICE Enovix Corporation (the “Company”), pursuant to its 2021 Equity Incentive Award Plan, as amended from time to time (the “Plan”), granted to the holder listed below (the “Participant”) on the grant date set forth below (the “Grant Date”), an award of performance stock units (“Performance Stock

Employment Agreement, dated April 14, 2025, by and between Enovix Corporation and Ryan Benton

Exhibit 10.1 March 14, 2025 Ryan Benton Re: Employment Terms Dear Ryan: Enovix Corporation (the “Company”) is pleased to offer you the position of Chief Financial Officer reporting to the Chief Executive Officer (the “CEO) subject to the terms and conditions provided herein effective as of the date you commence employment hereunder, which is expected to be on or around April 14, 2025 (the “Start D

Enovix Announces First Quarter 2025 Financial Results

Exhibit 99.1 Enovix Announces First Quarter 2025 Financial Results FREMONT, Calif., April 30, 2025 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for the first quarter 2025, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the first quarter of 2025, Enovix advanced acr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2025 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

1

Exhibit 99.1 Enovix Appoints Ryan Benton as Chief Financial Officer FREMONT, Calif., April 17, 2025 (GLOBE NEWSWIRE) – Enovix Corporation (Nasdaq: ENVX), a global high-performance battery company, announced the appointment of Ryan Benton as Chief Financial Officer (CFO). Mr. Benton brings over three decades of financial leadership experience. He previously held key roles at ASM International and s

Enovix To Acquire Korean Battery Cell Facility to Bolster Manufacturing Acquisition will support company’s efforts to meet growing demand in the defense industry

Exhibit 99.1 Enovix To Acquire Korean Battery Cell Facility to Bolster Manufacturing Acquisition will support company’s efforts to meet growing demand in the defense industry FREMONT, Calif. – April 3, 2025 – Enovix Corporation (Nasdaq: ENVX), a global high-performance battery company, today announced the acquisition of battery cell manufacturing assets from SolarEdge, located in South Korea. The

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

As filed with the U.S. Securities and Exchange Commission on February 25, 2025

As filed with the U.S. Securities and Exchange Commission on February 25, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation or organization) (I.R.

Filing Fee Table.

Calculation of Filing Fee Tables S-8 Enovix Corp Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

Enovix Insider Trading Policy

Exhibit 19.1 ENOVIX CORPORATION AMENDED AND RESTATED INSIDER TRADING POLICY APPROVED BY THE BOARD OF DIRECTORS ON JULY 14, 2021 AMENDED AND RESTATED ON NOVEMBER 7, 2023 INTRODUCTION This policy determines acceptable transactions in the securities of Enovix Corporation (the “Company” or “Enovix”) by our employees, directors and consultants (“team members”). During the course of your employment, dir

List of Subsidiaries

Exhibit 21.1 ENOVIX CORPORATION List of Subsidiaries Subsidiary Jurisdiction Enovix Battery (Shenzhen) Co., Ltd. China Enovix Operations Inc. Delaware Enovix HoldCo Limited Cayman Islands Enovix OpCo Limited Cayman Islands Enovix India Holdco LLC Delaware Enovix Malaysia Private Limited Malaysia Enovix International Holdco LLC Delaware Enovix Research and Development Services India Private Limited

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 29, 2024 o TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 29, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specified in

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2025 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fi

Enovix Announces Fourth Quarter and Full Year 2024 Financial Results

Exhibit 99.1 Enovix Announces Fourth Quarter and Full Year 2024 Financial Results FREMONT, Calif., February 19, 2025 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for the fourth quarter and full year 2024, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the fourth qu

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fi

Enovix Appoints Kristina Truong as Chief Accounting Officer

Exhibit 99.1 Enovix Appoints Kristina Truong as Chief Accounting Officer December 30, 2024 FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a Silicon Valley high-performance battery manufacturing company, today announced the appointment of Kristina Truong as its first Senior Vice President and Chief Accounting Officer. Kristina will oversee all accoun

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fi

Search to Replace Enovix CFO

Search to Replace Enovix CFO FREMONT, Calif., December 16, 2024 (GLOBE NEWSWIRE) – Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global leader in high-performance batteries, today announced that CFO Farhan Ahmad has left the company and that it is searching for a new CFO. CEO Raj Talluri said, “We thank Farhan for his service, which left us with a healthy balance sheet with over $250 million of

Underwriting Agreement, dated October 30, 2024, by and between Enovix Corporation and Cantor Fitzgerald & Co.

Exhibit 1.1 ENOVIX CORPORATION 10,416,667 Shares of Common Stock (par value $0.0001 per share) Underwriting Agreement October 30, 2024 Cantor Fitzgerald & Co. As Representative of the several Underwriters listed in Schedule A hereto c/o Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Ladies and Gentlemen: Enovix Corporation, a Delaware corporation (the “Company”), proposes to issue and

Enovix Announces Proposed Public Offering of Common Stock

Exhibit 99.1 Enovix Announces Proposed Public Offering of Common Stock FREMONT, Calif., October 30, 2024 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (NASDAQ: ENVX), a global high-performance battery company, today announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock, subject to market and other conditions. In connection with the offer

Enovix Announces Pricing of Public Offering of Common Stock

Exhibit 99.2 Enovix Announces Pricing of Public Offering of Common Stock FREMONT, Calif., October 30, 2024 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (NASDAQ: ENVX), a global high-performance battery company, today announced the pricing of an underwritten public offering of 10,416,667 shares of its common stock for total gross proceeds of $100 million before deducting underwriting discounts

$100,000,000 Common Stock

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-273858 PROSPECTUS SUPPLEMENT (To prospectus dated August 18, 2023) $100,000,000 Common Stock We are offering $100,000,000 of shares of our common stock, par value $0.0001 per share, in this offering. Our common stock is listed on The Nasdaq Global Select Market under the symbol “ENVX.” On October 29, 2024, the last reported sa

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

Subject to Completion, dated October 30, 2024

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-273858 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, nor are they soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permi

Amendment No.2 to Manufacturing Agreement dated October 29, 2024, by and between Enovix Corporation and YBS International Berhad

Exhibit 10.1 Certain identified information marked by [*****] has been excluded from this exhibit because it is both (i) not material and (ii) the type of information that the Registrant both customarily and actually treats as private and confidential AMENDMENT NO. 2 TO MANUFACTURING AGREEMENT This Amendment No. 2 to Manufacturing Agreement (“Amendment No. 2”) is made and entered into as of the la

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2024 o TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Spe

Enovix Announces Third Quarter 2024 Financial Results

Exhibit 99.1 Enovix Announces Third Quarter 2024 Financial Results FREMONT, Calif., October 29, 2024 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for third quarter 2024, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the third quarter of 2024, we made significant p

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

2 3501 W. Warren Blvd. | Fremont, CA 94538 | USA | www.enovix.com

August 8, 2024 VIA EDGAR Stephany Yang Kevin Woody Division of Corporation Finance Office of Manufacturing United States Securities and Exchange Commission Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 o TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specifie

Filing Fee Table.

Calculation of Filing Fee Tables S-8 Enovix Corp Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

Filing Fee Table

Calculation of Filing Fee Tables S-3 Enovix Corp Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Equity Common Stock, par value $0.

As filed with the U.S. Securities and Exchange Commission on August 5, 2024

S-3ASR 1 enovix-sx3asr.htm S-3ASR As filed with the U.S. Securities and Exchange Commission on August 5, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENOVIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incor

As filed with the U.S. Securities and Exchange Commission on August 5, 2024

As filed with the U.S. Securities and Exchange Commission on August 5, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation or organization) (I.R.S.

Form of Deregistration Representation Letter

Exhibit 4.4 ENOVIX CORPORATION CERTIFICATE The undersigned securityholder (the “Securityholder”) of Enovix Corporation, a Delaware corporation (the “Company”), is delivering this certificate to the Company in connection with the Securityholder’s warrants to purchase shares of Common Stock, par value $0.0001 per share, of the Company set forth on Schedule I hereto (the “Securities”). A.The Security

Enovix Announces Second Quarter 2024 Financial Results

Exhibit 99.1 Enovix Announces Second Quarter 2024 Financial Results FREMONT, Calif., July 31, 2024 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for second quarter 2024, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the second quarter of 2024 we began producing our

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2024 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  ☐ D

Form of 2024 Performance Stock Unit Award Grant Notice and Agreement under the 2021 Equity Incentive Plan

Exhibit 10.2 ENOVIX CORPORATION 2021 EQUITY INCENTIVE AWARD PLAN PERFORMANCE STOCK UNIT AWARD GRANT NOTICE Enovix Corporation (the “Company”), pursuant to its 2021 Equity Incentive Award Plan, as amended from time to time (the “Plan”), granted to the holder listed below (the “Participant”) on the grant date set forth below (the “Grant Date”), an award of performance stock units (“Performance Stock

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specifi

Amended and Restated Non-Employee Director Compensation Policy

Exhibit 10.1 Enovix Corporation Amended and Restated Non-Employee Director Compensation Policy Adopted by the Board of Directors: August 4, 2023 Each member of the Board of Directors (the “Board”) of Enovix Corporation (the “Company”) who is a non-employee director of the Company (each such member, a “Director” or “Non-Employee Director”) will receive the compensation described in this Non-Employe

Enovix Announces First Quarter 2024 Financial Results

Exhibit 99.1 Enovix Announces First Quarter 2024 Financial Results FREMONT, Calif., May 1, 2024 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for first quarter 2024, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the first quarter of 2024 we made tremendous progress

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 Enovix Corporation (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Num

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

List of Subsidiaries

Exhibit 21.1 ENOVIX CORPORATION List of Subsidiaries Subsidiary Jurisdiction Enovix Operations Inc. Delaware Enovix HoldCo Limited Cayman Islands Enovix OpCo Limited Cayman Islands Enovix India Holdco LLC Delaware Enovix Malaysia Private Limited Malaysia Enovix International Holdco LLC Delaware Enovix Research and Development Services India Private Limited India Routejade Inc. (1) Korea (1) A majo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 o TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specified in

Incentive Compensation Recoupment Policy

Exhibit 97.1 Enovix, Inc. Incentive Compensation Recoupment Policy 1.Introduction The Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Enovix Corporation, a Delaware corporation (the “Company”), has determined that it is in the best interests of the Company and its shareholders to adopt this Incentive Compensation Recoupment Policy (this “Policy”) pr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Enovix Corporat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fi

Enovix Announces Fourth Quarter and Full Year 2023 Financial Results

Exhibit 99.1 Enovix Announces Fourth Quarter and Full Year 2023 Financial Results FREMONT, Calif., February 20, 2024 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, announced today financial results for fourth quarter and full year 2023, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the fourth quarter of 2

ENVX / Enovix Corporation / Park West Asset Management LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ENOVIX CORPORATION (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 293594107 (CUSIP Number) DECEMBER 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul

ENVX / Enovix Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0849-enovixcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Enovix Corp Title of Class of Securities: Common Stock CUSIP Number: 293594107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pur

Common Stock

424B7 Table of Contents Filed Pursuant to Rule 424(b)(7) Registration Statement No.

ENOVIX CORPORATION 3501 W. Warren Avenue Fremont, CA 94538

ENOVIX CORPORATION 3501 W. Warren Avenue Fremont, CA 94538 December 1, 2023 VIA EDGAR U.S. Securities and Exchange Commission Office of Manufacturing Division of Corporation Finance 100 F. Street N.E. Washington, D.C. 20549-3010 Attention: Evan Ewing Jay Ingram RE: Enovix Corporation Registration Statement on Form S-3 Filed November 13, 2023 File No. 333-275524 Ladies and Gentlemen: Enovix Corpora

As filed with the U.S. Securities and Exchange Commission on November 28, 2023

S-3/A Table of Contents As filed with the U.S. Securities and Exchange Commission on November 28, 2023 Registration No. 333-275524 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENOVIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jur

*** Cooley LLP 3175 Hanover Street Palo Alto, CA 94304-1130 t: +1 650 843 5000 f: +1 650 849 7400 cooley.com

John T. McKenna T: +1 650 843 5059 [email protected] November 28, 2023 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, NE Washington, D.C. 20549 Attention: Evan Ewing Jay Ingram RE: Enovix Corporation Registration Statement on Form S-3 Filed on November 13, 2023 File No. 333-275524 Ladies and Gentlemen: On behalf of Enovix Corporation

As filed with the U.S. Securities and Exchange Commission on November 13, 2023

S-3 Table of Contents As filed with the U.S. Securities and Exchange Commission on November 13, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENOVIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation

Filing Fee Table

EX-FILING FEES EXHIBIT 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Enovix Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, par value $0.

Cash Deposit Agreement dated September 13, 2023, by and between Enovix Corporation and OCBC Bank (Malaysia) Berhad

Exhibit 10.1 Certain identified information has been excluded from the exhibit because it is not material and would likely cause competitive harm to the company if publicly disclosed (INDIV/COMPANY/LLP & 1P/3 CASH DEPOSIT AGREEMENT To: OCBC BANK (MALAYSIA) BERHAD (Company No. 199401009721 / 295400-W) (“the Bank”) In consideration of the Bank (which expression shall include any persons deriving tit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2023 o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specif

Stock Purchase Agreement dated September 18,2023, by and between Enovix Corporation and Rene Limited

Exhibit 10.2 Certain identified information marked by [***] has been excluded from this exhibit because it is both (i) not material and (ii) the type of information that the Registrant both customarily and actually treats as private and confidential STOCK PURCHASE AGREEMENT by and between ENOVIX CORPORATION and RENE LIMITED September 18, 2023 TABLE OF CONTENTS STOCK PURCHASE AGREEMENT 1 Article 1

Enovix Announces Third Quarter 2023 Financial Results

Exhibit 99.1 Enovix Announces Third Quarter 2023 Financial Results FREMONT, Calif., November 7, 2023 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, announced today financial results for the third quarter of 2023, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the third quarter of 2023 we made meaningful st

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

Enovix Announces Strategic Realignment of Fab1 to Improve Operational Efficiency and Enhance Technology Development

Exhibit 99.1 Enovix Announces Strategic Realignment of Fab1 to Improve Operational Efficiency and Enhance Technology Development FREMONT, Calif., October 3, 2023 – Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced that it has initiated a strategic realignment of Fab1 in Fremont designed to refocus the facility from a manufacturing hub to its “Center

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2023 Enovix Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2023 Enovix Corpora

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission F

Emmanuel T. Hernandez to Retire from Enovix Board of Directors

Exhibit 99.1 Emmanuel T. Hernandez to Retire from Enovix Board of Directors FREMONT, Calif., September 28, 2023 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced that Emmanuel T. Hernandez will retire from the company’s board of directors effective September 30, 2023. Hernandez joined the board in July 2021 when Enovix became a publicly traded com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2023 Enovix Corpora

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission F

Enovix to Acquire Routejade

Exhibit 99.1 Enovix to Acquire Routejade •Buying existing coating supplier speeds product development, manufacturing efficiency, access to leading battery materials, path to strong margins, and supports manufacturing scale-up by reducing future capital expenditure need by approximately $35 million for coating capacity. •Establishes presence in Korea, strategically near key customers, equipment sup

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 Enovix Corpora

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission F

Up to $250,000,000 Common Stock

424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-273858 PROSPECTUS Up to $250,000,000 Common Stock We have entered into a Controlled Equity OfferingSM Sales Agreement, dated August 9, 2023, or the Sales Agreement, with Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc., or the Agents, relating to the sale of shares of our common stock, par value $0.0001 per share, offered by this prospe

ENOVIX CORPORATION 3501 W. Warren Avenue Fremont, CA 94538

ENOVIX CORPORATION 3501 W. Warren Avenue Fremont, CA 94538 August 16, 2023 VIA EDGAR U.S. Securities and Exchange Commission Office of Manufacturing Division of Corporation Finance 100 F. Street N.E. Washington, D.C. 20549-3010 Attention: Sarah Sidwell RE: Enovix Corporation Registration Statement on Form S-3 Filed August 9, 2023 File No. 333-273858 Ladies and Gentlemen: Enovix Corporation (the “R

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Enovix Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Debt Debt Securities(1) Rule 457(o) (2) (3) (3) — — Equity Preferred Stock, par value $0.

Form of Debt Securities Warrant Agreement and Warrant Certificate

EX-4.10 Exhibit 4.10 ENOVIX CORPORATION AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF ENOVIX CORPORATION FORM OF DEBT SECURITIES WARRANT AGREEMENT THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ENOVIX CORPORATION, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing

Employment Agreement, dated June 26, 2023, by and between Enovix Corporation and Farhan Ahmad

Exhibit 10.4 June 23, 2023 Farhan Ahmad 26 Woodside Dr, Moraga, CA United States Re: Employment Terms Dear Farhan: Enovix Corporation (the “Company”) is pleased to offer you the position of Chief Financial Officer reporting to the Chief Executive Officer (the “CEO). Your base salary will be $380,000 (the “Base Salary”) which will be subject to adjustment pursuant to the Company’s employee compensa

Form of Preferred Stock Warrant Agreement and Warrant Certificate

EX-4.9 Exhibit 4.9 ENOVIX CORPORATION AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF ENOVIX CORPORATION INC. FORM OF PREFERRED STOCK WARRANT AGREEMENT THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ENOVIX CORPORATION, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and exist

As filed with the U.S. Securities and Exchange Commission on August 9, 2023

As filed with the U.S. Securities and Exchange Commission on August 9, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation or organization) (I.R.S.

Form of Common Stock Warrant Agreement and Warrant Certificate

EX-4.8 Exhibit 4.8 ENOVIX CORPORATION AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF ENOVIX CORPORATION FORM OF COMMON STOCK WARRANT AGREEMENT THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ENOVIX CORPORATION, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the

Separation Agreement, dated June 28, 2023, by and between Enovix Corporation and Steffen Pietzke

Exhibit 10.3 CONSULTING AND SEPARATION AGREEMENT June 28, 2023 Steffen Pietzke VIA DOCUSIGN Dear Steffen: This letter sets forth the substance of the separation agreement (the “Agreement”) that Enovix Corporation (the “Company”) is offering to you to aid in your employment transition. 1)SEPARATION. Your employment termination date will be July 9, 2023, (the “Separation Date”). 2)Accrued Salary and

Manufacturing Agreement dated July 26, 2023, by and between Enovix Corporation and YBS International Berhad

Exhibit 10.1 Certain identified information marked by [***] has been excluded from this exhibit because it is both (i) not material and (ii) the type of information that the Registrant both customarily and actually treats as private and confidential MANUFACTURING AGREEMENT This Manufacturing Agreement (the “Agreement”) is made and entered into as of the last date of signature (the “Effective Date”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2023 o TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specified

As filed with the U.S. Securities and Exchange Commission on August 9, 2023

S-3 Table of Contents As filed with the U.S. Securities and Exchange Commission on August 9, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ENOVIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation or

Filing Fee Table.

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Enovix Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.

Form of Indenture

EX-4.6 Exhibit 4.6 ENOVIX CORPORATION Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20 Debt Securities TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee’s Certificate 8 Se

Controlled Equity OfferingSM Sales Agreement, by and among the Company, Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc., dated as of August 9, 2023

EX-1.2 Exhibit 1.2 Enovix Corporation Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement August 9, 2023 Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Oppenheimer & Co. Inc. 85 Broad Street Floor 23 New York, NY 10004 Ladies and Gentlemen: Enovix Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2023 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

Enovix Announces Second Quarter 2023 Financial Results

Exhibit 99.2 Enovix Announces Second Quarter 2023 Financial Results FREMONT, Calif., July 26, 2023 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, announced today financial results for the second quarter of 2023, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the second quarter of 2023 we made significant p

Enovix Signs Manufacturing Agreement with YBS International Berhad for Fab2 in Malaysia Agreement secures $70 million of non-dilutive funding

Exhibit 99.1 Enovix Signs Manufacturing Agreement with YBS International Berhad for Fab2 in Malaysia Agreement secures $70 million of non-dilutive funding FREMONT, Calif., July 26, 2023 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, announced today it has entered into a Master Service Agreement (“MSA”) with YBS International Berhad (“YBS”) (MESDAQ: YBS:KLS), a

Enovix Announces Farhan Ahmad as Chief Financial Officer

EX-99.1 Exhibit 99.1 Enovix Announces Farhan Ahmad as Chief Financial Officer FREMONT, Calif, June 29, 2023 — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced the appointment of Farhan Ahmad as Chief Financial Officer, replacing Steffen Pietzke, who is stepping down effective July 9, 2023. Pietzke will stay on as a consultant for up to six months t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

Enovix Announces Appointment of Joseph Malchow and Bernard Gutmann to Its Board of Directors

EX-99.1 Exhibit 99.1 Enovix Announces Appointment of Joseph Malchow and Bernard Gutmann to Its Board of Directors FREMONT, Calif, June 26, 2023 — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced the appointment of Joseph Malchow, founding partner at HNVR Technology Investment Management and board member at Enphase Energy, Inc., and Bernard Gutmann,

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 2, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specifie

Form of Global RSU Award Grant Notice under the 2023 Long-Term Incentive Plan

Exhibit 10.7 Enovix Corporation Global RSU Award Grant Notice (2021 Equity Incentive Plan) 2023 Long-Term Incentive Plan Award Enovix Corporation (the “Company”), pursuant to its 2023 Long-Term Incentive Plan (the “LTI Plan”) has awarded to you (the “Participant”) under the Company’s 2021 Equity Incentive Plan (the “Plan”) the number of restricted stock units (“RSUs”) specified and on the terms se

Employment Agreement, dated April 15, 2023, by and between Enovix Corporation and Arthi Chakravarthy

Exhibit 10.5 3501 W. Warren Ave, Fremont CA 94538 Ph:510-687-2350 April 13, 2023 Arthi Chakravarthy Los Altos, CA United States Re: Employment Terms Dear Arthi: Enovix Corporation (the “Company”) is pleased to offer you the position of Chief Legal Officer reporting to the Chief Executive Officer (the “CEO). Your base salary will be $350,000 (the “Base Salary”) which will be subject to adjustment p

2023 Long-Term Incentive Plan under the 2021 Equity Incentive Plan

Exhibit 10.6 ENOVIX CORPORATION LONG-TERM INCENTIVE PLAN 1. Purpose. As part of its employee compensation program, Enovix Corporation (the “Company”) has designed this Long-Term Incentive Plan (the “LTI Plan”). The LTI Plan provides Participants with incentive awards in the form of restricted stock units granted pursuant to the Enovix Corporation 2021 Equity Incentive Plan (the “2021 EIP”). The LT

definitive proxy statement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

Enovix Corporation Condensed Consolidated Balance Sheets (In Thousands, Except Share and per Share Amounts)

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, I am very pleased to announce that in the first quarter of 2023, we exceeded our expectations in four critical areas: First, we produced 12,500 full‑qual units, which beat our plan of 9,000 units, and was 2.8x over our 4,442‑unit production last quarter. This progress was enabled by across‑the‑board improvements in yield and productivity

Enovix Announces First Quarter 2023 Financial Results

Exhibit 99.2 Enovix Announces First Quarter 2023 Financial Results FREMONT, Calif., Apr. 26, 2023 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the first quarter 2023, ending April 2, 2023, and a new investor presentation. The quarterly sha

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 Enovix Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

Form of Global Note, representing Enovix Corporation’s 3.00% Convertible Senior Notes due 2028 (included as Exhibit A to the Indenture filed as Exhibit 4.1)

Exhibit 4.1 Execution Version ENOVIX CORPORATION AND U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of April 20, 2023 3.00% Convertible Senior Notes due 2028 TABLE OF CONTENTS Page Article 1 Definitions Section 1.01. Definitions 1 Section 1.02. References to Interest 16 Article 2 Issue, Description, Execution, Registration and Exchange of Notes Section 2.01. Designati

Enovix Announces Proposed $150 Million Offering of Convertible Senior Notes Due 2028

Exhibit 99.1 Enovix Announces Proposed $150 Million Offering of Convertible Senior Notes Due 2028 FREMONT, Calif., April 17, 2023 (GLOBE NEWSWIRE) - Enovix Corporation (“Enovix”) (NASDAQ: ENVX), an advanced silicon battery company, today announced its intent to offer $150 million aggregate principal amount of Convertible Senior Notes due 2028 (the “Notes”) in a private placement (the “Offering”) t

Form of Confirmation for Capped Call Transactions

Exhibit 10.1 [Dealer name and address] To: Enovix Corporation 3501 W Warren Avenue Fremont, California 94538 From: [Dealer] Re: [Base][Additional] Capped Call Transaction Date: [], 2023 Dear Ladies and Gentlemen: The purpose of this communication (this “Confirmation”) is to set forth the terms and conditions of the above-referenced transaction entered into on the Trade Date specified below (the “T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 Enovix Corporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

Amended and Restated Employment Agreement, dated January 20, 2023, by and between Enovix Corporation and Ralph Schmitt

Exhibit 10.31 3501 W. Warren Ave, Fremont CA 94538 Ph:510-687-2350 January 20, 2023 Ralph Schmitt Re: Employment Terms Dear Ralph: Enovix Corporation (the “Company”) is pleased to offer you continuing employment in the position of Chief Commercial Officer reporting to the Chief Executive Officer on the terms set forth herein. The terms set forth herein shall supersede and replace in entirety the t

Separation Agreement, dated January 13, 2023, by and between Enovix Corporation and Harrold Rust

Exhibit 10.26 January 13, 2023 Harrold Rust VIA DOCUSIGN Dear Harrold: This letter sets forth the substance of the separation agreement (the “Agreement”) that Enovix Corporation (the “Company”) is offering to you to aid in your employment transition. 1)Separation. Your employment termination date will be February 1st, 2023 (the “Separation Date”). You are also hereby resigning from (i) the Company

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 1, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specified in C

List of Subsidiaries

Exhibit 21.1 ENOVIX CORPORATION List of Subsidiaries Subsidiary Jurisdiction Enovix Operations Inc. Delaware Enovix HoldCo Limited Cayman Islands Enovix OpCo Limited Cayman Islands Enovix India Holdco LLC Delaware

Employment Agreement, dated December 23, by and between Enovix Corporation and Raj Talluri

Exhibit 10.29 3501 W. Warren Ave, Fremont CA 94538 Ph:510-687-2350 December 23, 2022 Raj Talluri 10604 Ainsworth Drive Los Altos CA 94024 United States Re: Employment Terms Dear Raj: Enovix Corporation (the “Company”) is pleased to offer you the position of Chief Executive Officer reporting to the Board of Directors (the “Board”). Your base salary will be $545,000 (the “Base Salary”) which will be

Long-Term Incentive Plan under the 2021 Equity Incentive Plan

Exhibit 10.4 ENOVIX CORPORATION LONG-TERM INCENTIVE PLAN 1. Purpose. As part of its employee compensation program, Enovix Corporation (the “Company”) has designed this Long-Term Incentive Plan (the “LTI Plan”). The LTI Plan provides Participants with incentive awards in the form of restricted stock units granted pursuant to the Enovix Corporation 2021 Equity Incentive Plan (the “2021 EIP”). The LT

Separation Agreement, dated January 17, 2023, by and between Enovix Corporation and Ashok Lahiri

Exhibit 10.28 January 17, 2023 Ashok Lahiri VIA DOCUSIGN Dear Ashok: This letter sets forth the substance of the separation agreement (the “Agreement”) that Enovix Corporation (the “Company”) is offering to you to aid in your employment transition. 1)Separation. Your employment termination date will be February 1st, 2023 (the “Separation Date”). 2)Accrued Salary and Paid Time Off. On the Separatio

Employment Agreement, dated November 9, 2022, by and between Enovix Corporation and Ajay Marathe

Exhibit 10.30 3501 W. Warren Ave, Fremont CA 94538 Ph:510-687-2350 November 9, 2022 Ajay Marathe Re: Employment Terms Dear Ajay: Enovix Corporation (the “Company”) is pleased to offer you the position of Chief Operating Officer, reporting to the Chief Executive Officer. Your base salary will be $450,000 (the “Base Salary”) which will be subject to adjustment pursuant to the Company’s employee comp

Separation Agreement, dated January 20, 2023, by and between Enovix Corporation and Gardner Cameron Dales

Exhibit 10.27 January 20, 2023 Cameron Dales VIA DOCUSIGN Dear Cameron: This letter sets forth the substance of the separation agreement (the “Agreement”) that Enovix Corporation (the “Company”) is offering to you to aid in your employment transition. 1)Separation. Your employment termination date will be February 1st, 2023 (the “Separation Date”). 2)Accrued Salary and Paid Time Off. On the Separa

Enovix Announces Fourth Quarter and Full Year 2022 Financial Results

EX-99.2 3 envx8k-q420230222ex992.htm EX-99.2 Exhibit 99.2 Enovix Announces Fourth Quarter and Full Year 2022 Financial Results FREMONT, Calif., Feb. 22, 2023 - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the fourth quarter and full year 202

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fi

Enovix Corporation Consolidated Balance Sheets (In Thousands, Except Share and per Share Amounts)

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, In the fourth quarter of 2022, we delivered record unit shipments, Fab-1 yield, and customer progression through our revenue funnel. We have begun our journey to scale with new leadership that is rolling up its sleeves to drive shareholder value. Recent improvements in manufacturing support our forecast to more than double battery cell o

As filed with the U.S. Securities and Exchange Commission on February 17, 2023.

POS AM 1 enovix-resalesx1posamno2de.htm POS AM NO.2 As filed with the U.S. Securities and Exchange Commission on February 17, 2023. Registration No. 333-258358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its char

Joint Filing Agreement dated February 14, 2023

EX-99.1 2 enovixsc13daex9912142023.htm EX-99.1 Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13(d)-1(k) The undersigned acknowledge and agree that the foregoing Amendment No. 2 to statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D, as amended, shall be filed on behalf of each of the undersigned without

ENVX / Enovix Corporation / Park West Asset Management LLC Passive Investment

SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* ENOVIX CORPORATION (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 PER SHARE (Title of Class of Securities) 293594107 (CUSIP Number) DECEMBER 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriat

ENVX / Enovix Corporation / RODGERS THURMAN J - SC 13D/A NO.2 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* ENOVIX CORPORATION (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 293594107 (CUSIP Number) Thurman J. Rodgers 535 Eastview Way Woodside, CA 94062 (Name, Address and Telephone Number of Person Authorized to Recei

ENVX / Enovix Corporation / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SC 13G 1 tv0825-enovixcorp.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Enovix Corp. Title of Class of Securities: Common Stock CUSIP Number: 293594107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Sch

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2023 Enovix Corporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

ENVX / Enovix Corporation / Eclipse GP III, LLC - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ENOVIX CORPORATION (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 293594107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 10 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or supp

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 9 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 7 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 8 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or suppl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 Enovix Corporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2023 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fil

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2022 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorpora

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 3 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or suppl

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 4 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or suppl

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 6 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or suppl

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 5 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or suppl

Disclaimer This presentation (this “Presentation”) is provided solely for information purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity or debt. Enovix assumes no obl

EX-99.1 2 d443209dex991.htm EX-99.1 Exhibit 99.1 SPECIAL PRESENTATION to SHAREHOLDERS T.J. Rodgers Executive Chairman January 3, 2023 Disclaimer This presentation (this “Presentation”) is provided solely for information purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity or debt. Enovix assumes no obligation to updat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2023 Enovix Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2023 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2022 Enovix Corporat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2022 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2022 Enovix Corporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2022 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fil

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 2 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated June 17, 2022 (as amended or suppl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2022 o TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specif

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2022 Enovix Corporati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2022 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

Enovix Corporation Condensed Consolidated Balance Sheets (In Thousands, Except Share and per Share Amounts)

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, In the third quarter of 2022, we made steady operational progress in Fab-1 that allowed us to improve yield while also continuing to ship cells from our production line for qualification programs and pre-production end-product builds. Production cells were shipped to 25 OEMs, including three Strategic Accounts, a tier one lithium-ion bat

Enovix Announces Third Quarter 2022 Financial Results

Exhibit 99.2 Enovix Announces Third Quarter 2022 Financial Results FREMONT, Calif., November 1, 2022 (GLOBE NEWSWIRE) - Enovix Corporation (“Enovix”) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the third quarter

As filed with the U.S. Securities and Exchange Commission on August 24, 2022

As filed with the U.S. Securities and Exchange Commission on August 24, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation or organization) (I.R.S.

Filing Fee Table.

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) Enovix Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.

Forms of Restricted Stock Unit Grant Notice for Long-Term Incentive Plan Award and Restricted Stock Unit Award Agreement under the 2021 Equity Incentive Plan

EXHIBIT 10.1 Enovix Corporation Global RSU Award Grant Notice (2021 Equity Incentive Plan) Long-Term Incentive Plan Award Enovix Corporation (the ?Company?), pursuant to its Long-Term Incentive Plan (the ?LTI Plan?) has awarded to you (the ?Participant?) under the Company?s 2021 Equity Incentive Plan (the ?Plan?) the number of restricted stock units (?RSUs?) specified and on the terms set forth be

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

424B3 1 envx424b320220816prospectu.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 1 (To the Prospectus dated June 17, 2022) Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2022 o TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto Enovix Corporation (Exact Name of Registrant as Specified

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2022 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

Enovix Corporation Condensed Consolidated Balance Sheets (In Thousands, Except Share and per Share Amounts)

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, For the second quarter of 2022, we reported first revenue, consisting of approximately $5.1 million of service revenue and a small contribution from commercial battery cells. This met a commitment we made in February 2021, when we projected first product revenue from Fab-1 in Fremont in Q2 2022. Service revenue for the second quarter inc

Enovix Announces Second Quarter 2022 Financial Results

Exhibit 99.2 Enovix Announces Second Quarter 2022 Financial Results FREMONT, Calif., August 10, 2022 (GLOBE NEWSWIRE) - Enovix Corporation (?Enovix?) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon? Lithium-ion batteries, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the second quarter

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2022 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File N

Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

424B3 1 d288800d424b3.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS Up to 66,655,781 Shares of Common Stock (Including up to 6,000,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus relates to the issuance by us of up to 6,000,000 shares of our common stock, $0.0001 par value per share

As filed with the U.S. Securities and Exchange Commission on June 14, 2022. Registration No. 333-258358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER TH

Table of Contents As filed with the U.S. Securities and Exchange Commission on June 14, 2022. Registration No. 333-258358 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 3359 85-3174357 (State o

List of Subsidiaries

Exhibit 21.1 ENOVIX CORPORATION List of Subsidiaries Subsidiary Jurisdiction Enovix Operations Inc. Delaware Enovix HoldCo Limited Cayman Islands Enovix OpCo Limited Cayman Islands Enovix India Holdco LLC Delaware

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2022 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enovix Corporation (Exact Name of Registrant as Specifi

5 Enovix Corporation Consolidated Balance Sheets (In Thousands, Except Share and per Share Amounts)

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, During the first quarter of 2022 we achieved two very important milestones: 1) we produced advanced 3D SiliconTM lithium-ion batteries for customers from our first production line for customer qualification, and 2) we announced BrakeFlowTM, a breakthrough in advanced lithium-ion battery safety. This critical innovation was possible due t

Enovix Announces First Quarter 2022 Financial Results

Exhibit 99.2 Enovix Announces First Quarter 2022 Financial Results FREMONT, Calif., May 11, 2022 (GLOBE NEWSWIRE) - Enovix Corporation (?Enovix?) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon? Lithium-ion batteries, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the first quarter of 2

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2022 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEFA14A 1 ny20002845x2defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Comm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.?) Filed by the Registrant ? ? ? Filed by a Party other than the Registrant ? ? ?? Check the appropriate box: ?? ? ? Preliminary Proxy Statement ?? ? ? Confidential, for Use of the Commissio

Exhibit 4.4

Exhibit 4.4 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description summarizes selected information regarding our capital stock, as well as relevant provisions of: (i) our amended and restated certificate of incorporation; (ii) our amended and restated bylaws; and (iii) the General Corporation Law of the State of

` UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 2, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

` UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 2, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enovix Corporation (Exact Name of Registrant as Specified i

ENVX / Enovix Corporation / York Capital Management Global Advisors, LLC Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. 1)* Enovix Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 293594107 (CUSIP Number) March 1, 2022** (Dat

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 03, 2022 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission File

Enovix Announces Fourth Quarter and Full Year 2021 Financial Results

Exhibit 99.2 Enovix Announces Fourth Quarter and Full Year 2021 Financial Results FREMONT, Calif., March 3, 2022 (GLOBE NEWSWIRE) - Enovix Corporation (?Enovix?) (Nasdaq: ENVX), the leader in the design and manufacture of next generation 3D Silicon? Lithium-ion batteries, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the fo

5 Enovix Corporation Consolidated Balance Sheets (In Thousands, Except Share and per Share Amounts)

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, We enter 2022 building and shipping batteries to tier one customers and are focused on: 1) increasing our ability to respond to a growing customer base, 2) leveraging our unique architecture to drive transformative product enhancements, and 3) capitalizing on our learning from our first production line. In January, we shipped the first s

ENVX / Enovix Corporation / York Capital Management Global Advisors, LLC Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. )* Enovix Corporation (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 293594107 (CUSIP Number) December 31, 2021 (Da

ENVX / Enovix Corporation / GILDER GAGNON HOWE & CO LLC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (RULE 13d - 102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (Amendment No.2)* Enovix Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 293594107 CUSIP Number) December 31, 2021 (Date of Event

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2022 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fil

ENVX / Enovix Corporation / Electron Capital Partners, LLC - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Enovix Corp. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 293594107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th

Enovix Executives Provide Update to EV Program at the 21st Advanced Automotive Battery Conference in San Diego

Exhibit 99.1 Enovix Executives Provide Update to EV Program at the 21st Advanced Automotive Battery Conference in San Diego FREMONT, Calif., Dec. 7, 2021 ? Enovix Corporation (?Enovix?) (Nasdaq: ENVX, ENVXW), the leader in the design and manufacture of next-generation 3D Silicon? Lithium-ion batteries, announced today its executives will be speaking at the 21st Advanced Automotive Battery Conferen

1

Exhibit 99.4 From Mobile Electronics to Electric Vehicles By Ashok Lahiri, CTO and Co-Founder and Cam Dales, GM and CCO It?s an exciting time for electric vehicles. With rapidly growing sales, many new models entering the market and substantial investments from both automotive OEMs and governments globally, the U.S. government?s goal of reaching 40-50% EV sales by 2030 seems within reach. Today, w

The Enovix Advantage Step-Change Increase in Validation from Category-Leading Patented Battery Architecture and 100% Active Silicon Anode Energy Density Process Technology Customers Scaling Up Production with Focused on Premium Markets Attractive Fin

Exhibit 99.3 Enovix: From Mobile Electronics to EVs Cameron Dales General Manager and Chief Commercial Officer December 7, 2021 ?2021 ENOVIX Disclaimer This presentation (this ?Presentation?) is provided solely for information purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity or debt. The information contained here

The Enovix Advantage Step-Change Increase in Validation from Category-Leading Patented Battery Architecture and 100% Active Silicon Anode Energy Density Process Technology Customers Scaling Up Production with Focused on Premium Markets Attractive Fin

Exhibit 99.2 Enovix Overview Ashok Lahiri CTO and Co-Founder December 7, 2021 ?2021 ENOVIX Disclaimer This presentation (this ?Presentation?) is provided solely for information purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity or debt. The information contained herein does not purport to be all-inclusive. The data

Enovix Announces Redemption of Public Warrants

Exhibit 99.1 Enovix Announces Redemption of Public Warrants FREMONT, CA, December 7, 2021 (GLOBE NEWSWIRE) ? Enovix Corporation (?Enovix?) (Nasdaq: ENVX, ENVXW), the leader in the design and manufacture of next generation 3D Silicon? Lithium-ion batteries, today announced that holders of its outstanding public warrants will have until 5:00 p.m, New York City time, on January 7, 2022, to exercise t

NOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 293594115)

Exhibit 99.2 December 7, 2021 NOTICE OF REDEMPTION OF PUBLIC WARRANTS (CUSIP 293594115) Dear Public Warrant Holder, Enovix Corporation (the ?Company?) hereby gives notice that it is redeeming, at 5:00 p.m., New York City time, on January 7, 2022 (the ?Redemption Date?), all of the Company?s outstanding public warrants (the ?Public Warrants?) to purchase shares of the Company?s common stock, par va

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2021 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fil

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2021 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fil

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 9 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 7 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 6 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 8 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 001-39753 85-3174357 (State or other jurisdiction of incorporation) (Commission Fi

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 5 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 3, 2021 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 3, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enovix Corporation (Exact Name of Registrant as Speci

Technology Executive, Pegah Ebrahimi, Appointed to Enovix Board of Directors

Exhibit 99.1 Technology Executive, Pegah Ebrahimi, Appointed to Enovix Board of Directors FREMONT, Calif., Nov. 8, 2021 (GLOBE NEWSWIRE) ? Enovix Corporation (?Enovix?) (Nasdaq: ENVX, ENVXW), the leader in the design and manufacture of next generation 3D Silicon? Lithium-ion batteries, today announced the appointment of Pegah Ebrahimi to its Board of Directors. Ebrahimi is a seasoned technology ex

Enovix Announces Third Quarter 2021 Financial Results

Exhibit 99.2 Enovix Announces Third Quarter 2021 Financial Results FREMONT, Calif., November 8, 2021 (GLOBE NEWSWIRE) - Enovix Corporation (?Enovix?) (Nasdaq: ENVX, ENVXW), the leader in the design and manufacture of next generation 3D Silicon? Lithium-ion batteries, today posted to its website at https://ir.enovix.com a quarterly shareholder letter containing the financial results for the third q

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 08, 2021 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fi

October 3,

Exhibit 99.1 Letter to Our Shareholders Fellow Shareholders, We made meaningful progress this quarter in the scale-up of our advanced battery production facility (?Fab-1?) in Fremont, California. Importantly in September we began to manufacture battery cells from the first automated production line installed in Fab-1. Achieving this milestone was the culmination of 14 years of development work, bo

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2021 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

Enovix Corporation Non-Employee Director Compensation Policy

Exhibit 10.1 ENOVIX CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION POLICY ADOPTED BY THE BOARD OF DIRECTORS: OCTOBER 20, 2021 EFFECTIVE: JULY 14, 2021 Each member of the Board of Directors (the ?Board?) of Enovix Corporation (the ?Company?) who is a non-employee director of the Company (each such member, a ?Director? or ?Non-Employee Director?) will receive the compensation described in this Non-E

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2021 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission Fil

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2021 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 85-3174357 (State or Other Jurisdiction of Incorporation) (Commission F

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 4 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

September 23, 2021 (File No. 333-259730)

As filed with the U.S. Securities and Exchange Commission on September 22, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Enovix Corporation (Exact name of registrant as specified in its charter) Delaware 85-3174357 (State or other jurisdiction of incorporation or organization) (I.R

JOINT FILING AGREEMENT PURSUANT TO RULE 13(d)-1(k)

Exhibit 99.1 JOINT FILING AGREEMENT PURSUANT TO RULE 13(d)-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned ac

ENVX / Enovix Corporation / RODGERS THURMAN J - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* ENOVIX CORPORATION (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 293594107 (CUSIP Number) Thurman J. Rodgers 535 Eastview Way Woodside, CA 94062 (Name, Address and Telephone Number of Person Authorized to Recei

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 3 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 2 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (as amended, th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Enovix Corporation (Exact Name of Registrant as Specifi

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258358 PROSPECTUS SUPPLEMENT NO. 1 (To the Prospectus dated August 10, 2021) Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock This prospectus supplement supplements the prospectus, dated August 10, 2021 (the ?Prospectu

ENOVIX CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and par value amounts)

Exhibit 99.1 ENOVIX CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share and par value amounts) (Unaudited) June 30, December 31, 2021 2020 Assets Current assets: Cash and cash equivalents $ 4,951 $ 29,143 Deferred contract costs 4,280 2,955 Prepaid expenses and other current assets 1,967 946 Total current assets 11,198 33,044 Property and equipment, net 50,701 31,290 Oper

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2021 Enovix Corporation (Exact name of Registrant as Specified in Its Charter) Delaware 001-39753 20-5871008 (State or Other Jurisdiction of Incorporation) (Commission File

[ENOVIX LOGO] [GRAPHIC] Letter to Our Shareholders August 2021 Q2 2021

Exhibit 99.1 [ENOVIX LOGO] [GRAPHIC] Letter to Our Shareholders August 2021 Q2 2021 Dear Shareholders, We are excited to share our progress with you in our first quarterly shareholder letter as a public company. Last month, we completed our business combination with Rodgers Silicon Valley Acquisition Corp. (RSVAC) and our listing on Nasdaq (ENVX). This transaction brought in gross proceeds of appr

Up to 78,155,781 Shares of Common Stock (Including up to 17,500,000 Shares of Common Stock Issuable Upon Exercise of Warrants) Up to 6,000,000 Warrants to Purchase Common Stock

Table of Contents Index to Financial Statements Filed Pursuant to Rule 424(b)(3) Registration No.

RISK FACTORS

EX-99.3 4 envx-20210810ex993.htm EX-99.3 Exhibit 99.3 RISK FACTORS Investing in our securities involves a high degree of risk. Before you make a decision to buy our securities, you should carefully consider the risks and uncertainties described below together with all of the other information contained in our annual and quarterly reports and other filings with the U.S. Securities and Exchange Comm